PAA 2.63% 19.5¢ pharmaust limited

Great interview.I asked a question on the Investor Hub about...

  1. 284 Posts.
    lightbulb Created with Sketch. 377
    Great interview.

    I asked a question on the Investor Hub about FightMND funding. I was concerned that acceptance into the Healey Platform may have jeopardised the FightMND grant,

    However, MT as always, is one step ahead. The expansion of the OLE study is a logical step and assures that FightMND remain at the forefront of the program.

    Great news and very pleasing for the potential new patients!

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.